{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:06:55Z","timestamp":1782961615328,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:00:00Z","timestamp":1707523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["No. 2021YFA1100500"],"award-info":[{"award-number":["No. 2021YFA1100500"]}]},{"name":"Youth Program of Natural Science Foundation of Shandong","award":["ZR2023QH315"],"award-info":[{"award-number":["ZR2023QH315"]}]},{"name":"National Natural Science Funds for Distinguished Young Scholar of China","award":["81625003"],"award-info":[{"award-number":["81625003"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930016"],"award-info":[{"award-number":["81930016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youth Program of Natural Science Foundation of Zhejiang Province","award":["LQ17H160006"],"award-info":[{"award-number":["LQ17H160006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background and aims<\/jats:title><jats:p>Due to a lack of donor grafts, steatotic livers are used more often for liver transplantation (LT). However, steatotic donor livers are more sensitive to ischemia\u2013reperfusion (IR) injury and have a worse prognosis after LT. Efforts to optimize steatotic liver grafts by identifying injury targets and interventions have become a hot issue.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Mouse LT models were established, and 4D label-free proteome sequencing was performed for four groups: normal control (NC) SHAM, high-fat (HF) SHAM, NC LT, and HF LT to screen molecular targets for aggravating liver injury in steatotic LT. Expression detection of molecular targets was performed based on liver specimens from 110 donors to verify its impact on the overall survival of recipients. Pharmacological intervention using small-molecule inhibitors on an injury-related target was used to evaluate the therapeutic effect. Transcriptomics and metabolomics were performed to explore the regulatory network and further integrated bioinformatics analysis and multiplex immunofluorescence were adopted to assess the regulation of pathways and organelles.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>HF LT group represented worse liver function compared with NC LT group, including more apoptotic hepatocytes (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01) and higher serum transaminase (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Proteomic results revealed that the mitochondrial membrane, endocytosis, and oxidative phosphorylation pathways were upregulated in HF LT group. Fatty acid binding protein 4 (FABP4) was identified as a hypoxia-inducible protein (fold change\u2009&gt;\u20092 and<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) that sensitized mice to IR injury in steatotic LT. The overall survival of recipients using liver grafts with high expression of FABP4 was significantly worse than low expression of FABP4 (68.5 vs. 87.3%,<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Adoption of FABP4 inhibitor could protect the steatotic liver from IR injury during transplantation, including reducing hepatocyte apoptosis, reducing serum transaminase (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), and alleviating oxidative stress damage (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). According to integrated transcriptomics and metabolomics analysis, cAMP signaling pathway was enriched following FABP4 inhibitor use. The activation of cAMP signaling pathway was validated. Microscopy and immunofluorescence staining results suggested that FABP4 inhibitors could regulate mitochondrial membrane homeostasis in steatotic LT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>FABP4 was identified as a hypoxia-inducible protein that sensitized steatotic liver grafts to IR injury. The FABP4 inhibitor, BMS-309403, could activate of cAMP signaling pathway thereby modulating mitochondrial membrane homeostasis, reducing oxidative stress injury in steatotic donors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Graphical Abstract<\/jats:title><\/jats:sec>","DOI":"10.1007\/s00018-023-05110-1","type":"journal-article","created":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T17:02:06Z","timestamp":1707584526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Integrated multi-omic analysis identifies fatty acid binding protein 4 as a biomarker and therapeutic target of ischemia\u2013reperfusion injury in steatotic liver transplantation"],"prefix":"10.1007","volume":"81","author":[{"given":"Mengfan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changbiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-2811","authenticated-orcid":false,"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,10]]},"reference":[{"issue":"10","key":"5110_CR1","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1002\/lt.25320","volume":"24","author":"AS Bodzin","year":"2018","unstructured":"Bodzin AS, Baker TB (2018) Liver transplantation today: where we are now and where we are going. Liver Transpl 24(10):1470\u20131475","journal-title":"Liver Transpl"},{"issue":"10290","key":"5110_CR2","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M (2021) Non-alcoholic fatty liver disease. Lancet 397(10290):2212\u20132224","journal-title":"Lancet"},{"issue":"6","key":"5110_CR3","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","volume":"42","author":"PB Duell","year":"2022","unstructured":"Duell PB, Welty FK, Miller M et al (2022) Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol 42(6):e168\u2013e185","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"5110_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.870239","volume":"13","author":"SP Tang","year":"2022","unstructured":"Tang SP, Mao XL, Chen YH et al (2022) Reactive oxygen species induce fatty liver and ischemia-reperfusion injury by promoting inflammation and cell death. Front Immunol 13:870239","journal-title":"Front Immunol"},{"key":"5110_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijsu.2020.05.024","volume":"82S","author":"N Goldaracena","year":"2020","unstructured":"Goldaracena N, Cullen JM, Kim DS et al (2020) Expanding the donor pool for liver transplantation with marginal donors. Int J Surg 82S:30\u201335","journal-title":"Int J Surg"},{"issue":"2","key":"5110_CR6","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12072-018-9917-3","volume":"13","author":"B Aguilar-Bravo","year":"2019","unstructured":"Aguilar-Bravo B, Sancho-Bru P (2019) Laser capture microdissection: techniques and applications in liver diseases. Hepatol Int 13(2):138\u2013147","journal-title":"Hepatol Int"},{"issue":"2","key":"5110_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.14218\/JCTH.2021.00219","volume":"10","author":"Z Liu","year":"2022","unstructured":"Liu Z, Xu J, Que S et al (2022) Recent progress and future direction for the application of multiomics data in clinical liver transplantation. J Clin Transl Hepatol 10(2):363\u2013373","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"5110_CR8","first-page":"219","volume":"11","author":"Y Lin","year":"2023","unstructured":"Lin Y, Huang H, Chen L et al (2023) Assessing donor liver quality and restoring graft function in the era of extended criteria donors. J Clin Transl Hepatol 11(1):219\u2013230","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"5110_CR9","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1186\/s12885-020-07488-8","volume":"20","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhang Z, Zhou H et al (2020) Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma. BMC Cancer 20(1):1047","journal-title":"BMC Cancer"},{"issue":"8","key":"5110_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105096","volume":"9","author":"Y Wang","year":"2014","unstructured":"Wang Y, Tian Y, Ding Y et al (2014) MiR-152 may silence translation of CaMK II and induce spontaneous immune tolerance in mouse liver transplantation. PLoS ONE 9(8):e105096","journal-title":"PLoS ONE"},{"key":"5110_CR11","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3389\/fphar.2019.01693","volume":"10","author":"R Zhang","year":"2019","unstructured":"Zhang R, Chu K, Zhao N et al (2019) Corilagin alleviates nonalcoholic fatty liver disease in high-fat diet-induced C57BL\/6 mice by ameliorating oxidative stress and restoring autophagic flux. Front Pharmacol 10:1693","journal-title":"Front Pharmacol"},{"issue":"6","key":"5110_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.236","volume":"8","author":"M Ge","year":"2017","unstructured":"Ge M, Yao W, Yuan D et al (2017) Brg1-mediated Nrf2\/HO-1 pathway activation alleviates hepatic ischemia-reperfusion injury. Cell Death Dis 8(6):e2841","journal-title":"Cell Death Dis"},{"key":"5110_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.710285","volume":"12","author":"P Zhang","year":"2021","unstructured":"Zhang P, Wang W, Mao M et al (2021) Similarities and differences: a comparative review of the molecular mechanisms and effectors of NAFLD and AFLD. Front Physiol 12:710285","journal-title":"Front Physiol"},{"key":"5110_CR14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.hbpd.2023.06.006","volume":"22","author":"MY Wu","year":"2023","unstructured":"Wu MY, Fan JG (2023) Gut microbiome and nonalcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int 22:444","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"4","key":"5110_CR15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/lt.24069","volume":"21","author":"J Huang","year":"2015","unstructured":"Huang J, Millis JM, Mao Y et al (2015) Voluntary organ donation system adapted to Chinese cultural values and social reality. Liver Transpl 21(4):419\u2013422","journal-title":"Liver Transpl"},{"issue":"3","key":"5110_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.hbpd.2022.10.005","volume":"22","author":"SL Gao","year":"2023","unstructured":"Gao SL, Mou BY, Dai DS et al (2023) Marginal donor liver versus standard donor liver: a single-center observational study. Hepatobiliary Pancreat Dis Int 22(3):239\u2013244","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"5110_CR17","unstructured":"\u4e2d\u534e\u533b\u5b66\u4f1a\u5668\u5b98\u79fb\u690d\u5b66\u5206\u4f1a (2019) \u4e2d\u56fd\u809d\u79fb\u690d\u4f9b\u809d\u83b7\u53d6\u6280\u672f\u89c4\u8303(2019\u7248). \u4e2d\u534e\u79fb\u690d\u6742\u5fd7 (\u7535\u5b50\u7248), 13(3): 167\u201370"},{"issue":"10","key":"5110_CR18","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1002\/bjs.9868","volume":"102","author":"LA Orci","year":"2015","unstructured":"Orci LA, Berney T, Majno PE et al (2015) Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation. Br J Surg 102(10):1250\u20131257","journal-title":"Br J Surg"},{"issue":"S1","key":"5110_CR19","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1002\/lt.24826","volume":"23","author":"M Hamar","year":"2017","unstructured":"Hamar M, Selzner M (2017) Steatotic donor livers: where is the risk-benefit maximized? Liver Transpl 23(S1):S34\u2013S39","journal-title":"Liver Transpl"},{"issue":"1","key":"5110_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/TP.0000000000002466","volume":"103","author":"I Linares","year":"2019","unstructured":"Linares I, Hamar M, Selzner N et al (2019) Steatosis in liver transplantation: current limitations and future strategies. Transplantation 103(1):78\u201390","journal-title":"Transplantation"},{"key":"5110_CR21","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3389\/fcell.2020.00826","volume":"8","author":"Z Liu","year":"2020","unstructured":"Liu Z, Zhu H, Wang W et al (2020) Metabonomic profile of macrosteatotic allografts for orthotopic liver transplantation in patients with initial poor function: mechanistic investigation and prognostic prediction. Front Cell Dev Biol 8:826","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"5110_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13116","volume":"54","author":"X Yang","year":"2021","unstructured":"Yang X, Lu D, Wang R et al (2021) Single-cell profiling reveals distinct immune phenotypes that contribute to ischaemia-reperfusion injury after steatotic liver transplantation. Cell Prolif 54(10):e13116","journal-title":"Cell Prolif"},{"issue":"3","key":"5110_CR23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3390\/jcm9030711","volume":"9","author":"J Xu","year":"2020","unstructured":"Xu J, Hassan-Ally M, Casas-Ferreira AM et al (2020) Deregulation of the purine pathway in pre-transplant liver biopsies is associated with graft function and survival after transplantation. J Clin Med 9(3):711","journal-title":"J Clin Med"},{"issue":"1","key":"5110_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/hep.25649","volume":"56","author":"DL Diamond","year":"2012","unstructured":"Diamond DL, Krasnoselsky AL, Burnum KE et al (2012) Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation. Hepatology 56(1):28\u201338","journal-title":"Hepatology"},{"issue":"7","key":"5110_CR25","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1194\/jlr.M074542","volume":"58","author":"AV Hertzel","year":"2017","unstructured":"Hertzel AV, Xu H, Downey M et al (2017) Fatty acid binding protein 4\/aP2-dependent BLT1R expression and signaling. J Lipid Res 58(7):1354\u20131361","journal-title":"J Lipid Res"},{"key":"5110_CR26","doi-asserted-by":"crossref","unstructured":"Xiao Y, Shu L, Wu X, et al (2021) Fatty acid binding protein 4 promotes autoimmune diabetes by recruitment and activation of pancreatic islet macrophages. JCI Insight 6(7)","DOI":"10.1172\/jci.insight.141814"},{"issue":"3","key":"5110_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3390\/cells8030227","volume":"8","author":"M Trojnar","year":"2019","unstructured":"Trojnar M, Patro-Malysza J, Kimber-Trojnar Z et al (2019) Associations between fatty acid-binding protein 4(-)a proinflammatory adipokine and insulin resistance, gestational and type 2 diabetes mellitus. Cells 8(3):227","journal-title":"Cells"},{"key":"5110_CR28","doi-asserted-by":"publisher","first-page":"101376","DOI":"10.1016\/j.redox.2019.101376","volume":"29","author":"M Lamas Bervejillo","year":"2020","unstructured":"Lamas Bervejillo M, Bonanata J, Franchini GR et al (2020) A FABP4-PPARgamma signaling axis regulates human monocyte responses to electrophilic fatty acid nitroalkenes. Redox Biol 29:101376","journal-title":"Redox Biol"},{"issue":"4","key":"5110_CR29","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jhep.2015.05.030","volume":"63","author":"B Hu","year":"2015","unstructured":"Hu B, Guo Y, Garbacz WG et al (2015) Fatty acid binding protein-4 (FABP4) is a hypoxia inducible gene that sensitizes mice to liver ischemia\/reperfusion injury. J Hepatol 63(4):855\u2013862","journal-title":"J Hepatol"},{"issue":"2","key":"5110_CR30","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jhep.2012.10.022","volume":"58","author":"RL Hoo","year":"2013","unstructured":"Hoo RL, Lee IP, Zhou M et al (2013) Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice. J Hepatol 58(2):358\u2013364","journal-title":"J Hepatol"},{"issue":"24","key":"5110_CR31","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1007\/s00018-016-2282-2","volume":"73","author":"F Zhang","year":"2016","unstructured":"Zhang F, Zhang L, Qi Y et al (2016) Mitochondrial cAMP signaling. Cell Mol Life Sci 73(24):4577\u20134590","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"5110_CR32","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-021-00433-y","volume":"23","author":"M Bonora","year":"2022","unstructured":"Bonora M, Giorgi C, Pinton P (2022) Molecular mechanisms and consequences of mitochondrial permeability transition. Nat Rev Mol Cell Biol 23(4):266\u2013285","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"5110_CR33","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/ncb2220","volume":"13","author":"LC Gomes","year":"2011","unstructured":"Gomes LC, di Benedetto G, Scorrano L (2011) During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol 13(5):589\u2013598","journal-title":"Nat Cell Biol"},{"issue":"4","key":"5110_CR34","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/CIRCRESAHA.116.309859","volume":"120","author":"L Fazal","year":"2017","unstructured":"Fazal L, Laudette M, Paula-Gomes S et al (2017) Multifunctional mitochondrial epac1 controls myocardial cell death. Circ Res 120(4):645\u2013657","journal-title":"Circ Res"},{"issue":"5","key":"5110_CR35","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bbadis.2016.11.010","volume":"1863","author":"JS Bhatti","year":"2017","unstructured":"Bhatti JS, Bhatti GK, Reddy PH (2017) Mitochondrial dysfunction and oxidative stress in metabolic disorders\u2014a step towards mitochondria based therapeutic strategies. Biochim Biophys Acta Mol Basis Dis 1863(5):1066\u20131077","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"5110_CR36","doi-asserted-by":"crossref","first-page":"e336","DOI":"10.1002\/mco2.336","volume":"4","author":"N Liu","year":"2023","unstructured":"Liu N, Huang L, Xu H et al (2023) Phosphatidylserine decarboxylase downregulation in uric acid-induced hepatic mitochondrial dysfunction and apoptosis. MedComm (2020) 4(4):e336","journal-title":"MedComm (2020)"},{"key":"5110_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.trim.2022.101537","volume":"72","author":"XH Lu","year":"2022","unstructured":"Lu XH, Zhang J, Xiong Q (2022) Suppressive effect erythropoietin on oxidative stress by targeting AMPK\/Nox4\/ROS pathway in renal ischemia reperfusion injury. Transpl Immunol 72:101537","journal-title":"Transpl Immunol"},{"issue":"1","key":"5110_CR38","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1038\/s41467-022-30629-5","volume":"13","author":"JS Pedersen","year":"2022","unstructured":"Pedersen JS, Rygg MO, Chrois K et al (2022) Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration. Nat Commun 13(1):2931","journal-title":"Nat Commun"},{"issue":"4","key":"5110_CR39","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1002\/mco2.327","volume":"4","author":"L Xuan","year":"2023","unstructured":"Xuan L, Ju Z, Skonieczna M et al (2023) Nanoparticles-induced potential toxicity on human health: applications, toxicity mechanisms, and evaluation models. MedComm (2020) 4(4):e327","journal-title":"MedComm (2020)"},{"issue":"1","key":"5110_CR40","doi-asserted-by":"publisher","first-page":"15758","DOI":"10.1038\/s41598-020-71308-z","volume":"10","author":"B Millare","year":"2020","unstructured":"Millare B, O\u2019Rourke B, Trayanova N (2020) Hydrogen peroxide diffusion and scavenging shapes mitochondrial network instability and failure by sensitizing ROS-induced ROS release. Sci Rep 10(1):15758","journal-title":"Sci Rep"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-05110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-023-05110-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-023-05110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:55:11Z","timestamp":1731286511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-023-05110-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5110"],"URL":"https:\/\/doi.org\/10.1007\/s00018-023-05110-1","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,10]]},"assertion":[{"value":"26 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The animal experiments were conducted according to the protocol approved by the Zhejiang University after the review by the Institutional Animal Care and Use Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients signed informed consent regarding publishing their data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"83"}}